One of the biotech industry’s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug companies are set to go public.

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

The agency has been mired by high-profile departures, feuds between top leaders, accusations of politicization, and low morale. It has lost thousands of employees to layoffs and resignations and ...

NewsGuard has collected 1,000 provably false statements in its False Claim Fingerprints database. Many involve misrepresented research.

More Americans will be exposed to foodborne illness as a result of this year's funding cuts, food safety experts predict ...

In the weeks leading up to Dec. 3, I imagined a fantastic headline: “Ozempic treats Alzheimer’s disease.” ...

The neutropenic diet, which calls for nearly all food to be cooked at high heat to decrease infection risk, was waning in cancer care. A new study could change that.

Despite uncertainty and concern buffeting Massachusetts hospitals, the state’s largest health system saw its finances improve ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

WASHINGTON — Brand drugmakers have agreed to donate bulk ingredients to a national stockpile as part of deals with the Trump ...

A vaccine adviser at the CDC with ties to health secretary Robert F. Kennedy Jr. is being given a new portfolio overseeing ...

With its vaccine schedule, “Denmark has made a values choice to accept preventable hospitalizations and illnesses that other ...